MENU
GOSS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Gossamer Bio (GOSS) Ownership - Who owns Gossamer Bio?
Gossamer Bio Inc is a clinical-stage biopharmaceutical company... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
3013 Science Park Road
Phone
+1 858 684-1300
Employees
135
Web
https://www.gossamerbio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
285.26M
P/E Ratio
N/A
Total Cash
294.52M
Projected Growth
N/A
Total Debt
202.88M
Revenue
114.7M
Risk (Beta)
2.29
Dividend Yield
N/A
Total Cash/Share
1.30
Total Debt/Equity
N/A
Revenue/Share
0.55 USD as % of share price
Fundamentals
GOSS
Capitalization
285M
P/E Ratio
N/A
Risk (Beta)
2.29
Dividend Yield
N/A
Total Cash
295M
Total Cash/Share
1.30
Total Debt
203M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.55%
Revenue
115M
ROE
N/A
Book Value
29.5M
P/B Ratio
8.09
Cash Flow
N/A
Earnings
-0.25
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
23K
Current Ratio
6.88
Current Revenue Per Employee
64682.76
Dividends Per Share - Security
N/A
EBITDA
-39.97M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-18.03
Shares Held By Institutions
175M
Shares Outstanding - Current
227M
Total Liabilities
286M
Total Volume MTD
N/A
Value
N/A
Gain YTD
28.233
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
3013 Science Park Road
Phone
+1 858 684-1300
Employees
135
Web
https://www.gossamerbio.com